June 16, 2023
Bristol-Myers Squibb Co. on Friday lobbed yet another challenge to landmark legislation allowing Medicare to negotiate drug prices, slamming the law as unconstitutional and not actually involving negotiations "in any ordinary sense of the word," according to a suit filed in New Jersey federal court.
June 06, 2023
Pharmaceutical giant Merck picked the first legal fight over landmark legislation letting Medicare negotiate drug prices, and the company showed up with bare-knuckle rhetoric and a Jones Day partner who told Law360 on Tuesday that the litigation "fits perfectly" into his mission of battling Uncle Sam's excesses.